Condition: Tympanic Membrane Perforation · Tympanic Membrane Inflammation · Surgery · Sponsor: Central Adelaide Local Health Network Incorporated
The general purpose of this study is to compare Chitosan-dextran (Chitodex) gel versus current standard of care, Gelfoam, as a middle ear (ME) and external auditory canal (EAC) packing agent as part of tympanoplasty, ossiculoplasty and mastoidectomy procedures.
This description comes directly from the study's public registry record.
Prof Peter-John Wormald, MD, · +61 8 82227158 · pjwormald@gmail.com
Emma Barry, BSc (Hons) · +61 8 82227158 · emma.barry@adelaide.edu.au
Always discuss trial participation with your own doctor first.
| The Queen Elizabeth Hospital | Adelaide, South Australia, Australia | Recruiting |
| The Memorial Hospital | North Adelaide, South Australia, Australia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06260618